...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >Prospective investigation of nasal mupirocin, hexachlorophene body wash, and systemic antibiotics for prevention of recurrent community-associated methicillin-resistant Staphylococcus aureus infections
【24h】

Prospective investigation of nasal mupirocin, hexachlorophene body wash, and systemic antibiotics for prevention of recurrent community-associated methicillin-resistant Staphylococcus aureus infections

机译:鼻部莫匹罗星,六氯芬洗液和全身性抗生素预防社区相关性耐甲氧西林金黄色葡萄球菌复发的前瞻性研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Recurrent community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) skin infections are an increasingly common problem. However, there are no data on the efficacy of decolonization regimens. We prospectively evaluated 31 patients with recurrent CA-MRSA skin infections who received nasal mupirocin, topical hexachlorophene body wash, and an oral anti- MRSA antibiotic. The mean number of MRSA infections after the intervention decreased significantly from baseline (0.03 versus 0.84 infections/month, P = <0.0001). This regimen appears promising at preventing recurrent CA-MRSA infections.
机译:复发性社区相关性耐甲氧西林金黄色葡萄球菌(CA-MRSA)皮肤感染是一个日益普遍的问题。但是,没有关于非殖民化治疗方案功效的数据。我们对31例复发性CA-MRSA皮肤感染的患者进行了前瞻性评估,这些患者接受了鼻部莫匹罗星,局部六氯酚沐浴液和口服抗MRSA抗生素治疗。干预后的平均MRSA感染数较基线显着下降(每月感染0.03比0.84,P = <0.0001)。该方案在预防复发性CA-MRSA感染方面似乎很有希望。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号